Literature DB >> 6970167

Cyclosporin receptor on mouse lymphocytes.

B Ryffel, P Donatsch, U Götz, M Tschopp.   

Abstract

Specific binding of [3H]-cyclosporin C (3H-CS-C), an immunosuppressive oligopeptide, was characterized on different mouse lymphocytes. The binding was saturable, time-dependent and reversible; and KD of 1.5 x 10(-7) M and maximum binding capacity Bmax of 35 pmol/4 x 10(6) cells was found for thymocytes. A computerized analysis of the data confirmed a single population of high affinity binding sites. Lymphocytes of different organs differed in their Bmax: thymus greater than spleen greater than mesenteric lymph node (pure T cells) greater than mesenteric lymph node (pure B cells). Erythrocytes did not show a specific binding.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970167      PMCID: PMC1458294     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  6 in total

1.  THE IMMUNOLOGICAL ROLE OF DIFFERENT LYMPHOID ORGANS IN THE CHICKEN. II. THE IMMUNOLOGICAL COMPETENCE OF THYMIC CELL SUSPENSIONS.

Authors:  N L WARNER
Journal:  Aust J Exp Biol Med Sci       Date:  1964-06

2.  Corticosteroids and lymphoid cells.

Authors:  H N Claman
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

3.  Studies on the mechanism of action of cyclosporin A.

Authors:  D Wiesinger; J F Borel
Journal:  Immunobiology       Date:  1980-01       Impact factor: 3.144

4.  Absolute macrophage dependency of T lymphocyte activation by mitogens.

Authors:  D L Rosenstreich; J J Farrar; S Dougherty
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

5.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

6.  Neurotensin: specific binding to synaptic membranes from rat brain.

Authors:  P Kitabgi; R Carraway; J Van Rietschoten; C Granier; J L Morgat; A Menez; S Leeman; P Freychet
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

  6 in total
  10 in total

1.  Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages.

Authors:  M D Chiara; F Bedoya; F Sobrino
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.

Authors:  L H Block; P M Sutter; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-11-02

4.  Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes.

Authors:  M K Bijsterbosch; G G Klaus
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

5.  Inhibition of mouse natural killer activity by cyclosporin A.

Authors:  R H Yanagihara; W H Adler
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

6.  Cyclosporin A: a new advance in transplantation.

Authors:  B D Kahan
Journal:  Tex Heart Inst J       Date:  1982-09

7.  Effects of cyclosporin A on humoral immunity to ticks and on cutaneous immediate and delayed hypersensitivity reactions to Ixodes ricinus L. salivary-gland antigens in re-infested rabbits.

Authors:  P Girardin; M Brossard
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

8.  Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.

Authors:  A W Thomson; D K Moon; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

9.  Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro.

Authors:  S P Nickell; L W Scheibel; G A Cole
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  Selective suppression of an early step in human B cell activation by cyclosporin A.

Authors:  A Muraguchi; J L Butler; J H Kehrl; R J Falkoff; A S Fauci
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.